stroke
Genedrive Point-of-Care PGx Test for Stroke Patients Nabs UKCA Mark
The test can determine which stroke patients may respond to clopidogrel treatment in about one hour.
Protein Risk Score Alongside Genetic, Clinical Factors Modestly Improves Cardiovascular Disease Prediction
A protein risk score slightly improved atherosclerotic cardiovascular disease risk prediction when added to polygenic risk scores and clinical risk factors.
UK's NICE Recommends Genetic Testing for Therapy Selection in Stroke Patients
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.
Genomics PLC to Provide Polygenic Risk Scores for UK's Our Future Health Research Program
The company will work in partnership with Our Future Health to generate risk scores for up to 5 million people and to create methods for providing feedback to participants.
Stroke Risk Contributors, Treatment Targets Uncovered in Cross-Ancestry GWAS
Starting with a GWAS meta-analysis that included more than 110,000 stroke patients, researchers found new risk loci and developed polygenic scores for risk prediction.